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Automatic Burst Extrastimulus Pacemaker to Treat Recurrent
Ventricular Tachycardia in a Patient With Mitral Valve Prolapse:
More Than 2,000 Documented Successful Tachycardia Terminations*
JAMES R. HIGGINS, MD, FACC
Lack/and Air Force Base. Texas
An automatic burst pacemaker (Cybertach-60l was used
to treat drug-resistant recurrent ventricular tachycardia
in a patient with mitral valve prolapse. The arrhythmia
wasassociated with multiple syncopalepisodesand aborted
sudden death. During a 23 month follow-up period the
Various permanent pacemaking methods have been used in
the management of patients with recurrent ventricular tachy-
cardia ( 1-8). Three general types of antitachycardia devices
are available: I) underdrive, 2) scanning, and 3) burst pace-
makers. Underdrive pacemakers deliver random stimuli, and
thus have limited value in treating hemodynamically sig-
nificant tachyarrhythmias. We, along with other investi-
gators (9-12), have successfully used permanent scanning
pacemakers to treat sustained supraventricular and ventric-
ular tachycardias. Burst pacemakers have also been thera-
peutically useful, but acceleration of ventricular tachycardia
or induction of ventricular fibrillation, or both, has been
frequently reported (1,3,5-8,13).
This report outlines the successful use of an automatic
burst pacemaker (Cybertach-60, lntermedics, Inc) to treat
recurrent symptomatic ventricular tachycardia in a patient
with mitral valve prolapse whose condition had failed to
improve with the use of conventional and investigational
medications. At 23 months after implantation, the patient
remains asymptomatic and ambulatory electrocardiographic
(Holter) recordings have demonstrated more than 2,000 suc-
cessful terminations of ventricular tachycardia.
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patient has remained asymptomatic and more than 2,000
episodes of ventricular tachycardia have been success-
fully terminated by the pacemaker.
(J Am Coll CardioI1986;8:446-50)
Case Report
History. A 36 year old woman was diagnosed as having
mitral valve prolapse in October 1979 after complaining of
episodes of palpitation. In February 1980 she had a syncopal
episode and an electrocardiogram revealed wide complex
tachycardia at 180 beats/min (Fig. I). Over the next several
months, adverse side effects necessitated discontinuation of
quinidine, disopyramide and propranolol. In January 1981,
a second syncopal episode occurred while she was taking
metroprolol, and procainamide was added. Several episodes
of near syncope subsequently occurred, resulting in hos-
pitalization in June 1981. During hospitalization, while tak-
ing an increased procainamide dosage, the patient had mon-
itored wide complex tachycardia at 230 beats/min,
hemodynamic collapse and subsequent cardiopulmonary re-
suscitation, requiring ventilatory support for several days.
In August 1981, mexiletine therapy was started. For the
next 2 1/1 years the patient had mild episodes of palpitation,
and 20 ambulatory electrocardiographic (Holter) recordings
revealed frequent ventricular premature depolarizations, in-
cluding ventricular couplets and triplets but no higher re-
petitive forms. In March 1984, multiple near syncopal ep-
isodes resulted in another hospitalization at our institution.
Physical examination and laboratory evaluation, The
cardiac examination was normal except for a loud midsys-
tolic click without murmur. Blood chemistry values, chest
X-ray film and the baseline electrocardiogram were normal.
Echocardiography demonstrated mitral valve prolapse but
normal chamber size and function. Three separate exercise
stress tests (including one thallium stress test) using the
standard Bruce protocol showed no electrocardiographic
changes, angina, arrhythmias or perfusion abnormalities.
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Figure 1. Twelve lead electrocardiogram ob-
tained in February 1980 during the patient's
emergency room visit for syncope. The ven-
tricular tachycardia is slightly irregular at a rate
of 175/min. This same 12 lead configuration for
ventricular tachycardia was recorded sponta-
neously several times and was induced more
than 300 times in the electrophysiology labo-
ratory before pacemakerimplantation. Standard
electrocardiographic leads are labeled.
Figure 2. Segmentof a full disclosureHolter electrocardiographic
recording demonstrating three self-terminating episodes of sus-
tained ventricular tachycardia, each associated with presyncope.
The tachycardia rate is approximately I 65/min. Each line of re-
cording corresponds to approximately 25 seconds.
and successfully terminated. The patient had an uneventful
recovery from pacemaker implantation.
Cybertach-60 pacemaker. The Cybertach-60 pace-
maker is one of the first automatic implantable pacemakers
available for antitachycardia pacing in which both tachy-
cardia identification criteria and terminating responses are
programmable after implantation. The tachycardia recog-
nition algorithm is simple, recognizing a heart rate exceed-
ing the programmed rate. Thus, any eight consecutive cycles
at a rate greater than the programmed tachycardia criteria
will result in burst pacing output from the pacemaker. The
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Holter ambulatory electrocardiographic recordings demon-
strated multiple episodes of sustained ventricular tachycar-
dia (Fig. 2), each associated with near syncope. Electro-
cardiographic 12 lead recordings during symptoms were
identical to that in Figure 1. All medications were discon-
tinued but symptoms and tachyarrhythmias continued. The
patient refused multiple experimental medications including
amiodarone. Because she wished to consider antitachycardia
pacemaker therapy, an electrophysiologic evaluation was
performed.
Electrophysiologic testing. An electrophysiologic study
was performed utilizing standard techniques. Sinus node
and atrioventricular (AV) node function were normal, and
neither atrial overdrive pacing nor programmed stimulation
induced atrial supraventricular arrhythmia. Monomorphic
sustained ventricular tachycardia was repeatedly induced by
double extrastimuli at the right ventricular apex. The in-
duced ventricular tachycardia was identical in configuration
to that observed clinically. Single or double stimuli, or both,
delivered at the right ventricular apex were unsuccessful in
terminating ventricular tachycardia. However, timed burst
pacing with six stimuli at 250 ms terminated 100 consecutive
episodes of ventricular tachycardia without rate acceleration
(Fig. 3).
Pacemaker implantation. After the electrophysiologic
test, the patient again refused therapy with several inves-
tigational antiarrhythmic medications, but preferred an im-
plantable anti tachycardia pacemaker. Institutional approval
for implantation of the Cybertach-60 was obtained. The
patient returned to the electrophysiology laboratory where
ventricular tachycardia was reproducibly induced utilizing
coupled extrastimuli at the right ventricular apex. After 100
consecutive episodes of ventricular tachycardia were suc-
cessfully terminated utilizing a burst rate of 240 pulses/min
for 1.3 seconds, the pacemaker was implanted and an ad-
ditional 50 episodes of ventricular tachycardia were induced
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Figure 3. E1ectrophysiologic study. A, Recording showing ven-
tricular tachycardia after induction by double extrastimuli. Atrio-
ventricular dissociation is present. The first of six paced stimuli
(p) is synchronized to the last ventricular complex without appre-
ciable change in the surface electrocardiographic configuration. B,
Continuation of the tracing from A. Pacing stimuli (p) continue
at 250 ms intervals until six are given. The first pacing stimulus
in this panel changes the surface electrocardiographic configura-
tion, and when pacing is discontinued, sinus rhythm resumes. More
than 250 successful terminations were documented in the electro-
physiology laboratory. HRA = high right atrial intracardiac lead;
RV = right ventricular intracardiac lead.
choice of tachycardia criteria is limited to two, although
different rate criteria can be manufactured by request. Ter-
minating responses are programmed by burst rate and du-
ration. Burst rates from 180 to 1,440 pulses/min (eight dif-
ferent settings) and burst duration from 0.33 to 5.3 seconds
(five steps) are available. Programmability of pulse width,
sensitivity, bradycardia stimulation rate and telemetry are
also available.
Follow-up. The patient has been observed for 23 months
since pacemaker implantation. She has remained asymp-
tomatic without dizziness, near syncope or syncope and has
undergone thirty 24 hour Holter monitor recordings, con-
firming 2,014 successful pacemaker terminations of ven-
tricular tachycardia (Fig. 4A and B). She is taking nadolol,
40 mg/day, which maintains her sinus rate below the pro-
grammed tachycardia criteria.
Discussion
Antitachycardia pacemakers. Continuous "overdrive
pacing" was reported in 1964 (14) as efficacious for sup-
pressing ventricular arrhythmias. Fixed rate "underdrive
B
Figure 4. A, Segment of a full disclosure Holter electrocardio-
graphic recording after implantation of the Cybertach-60 pace-
maker. Four episodes of ventricular tachycardia termination (ar-
rows) are shown. As in Figure 2, each line of recordingcorresponds
to 30 seconds. B, Dual channel recording of one episode of ven-
tricular tachycardia (VT) from A. The ninth beat of ventricular
tachycardia (eight cycle lengths) starts a sequence of six paced
beats (pace) at 250 ms intervals, resulting in termination of ven-
tricular tachycardia and resumption of sinus rhythm. (The first
stimulus occurs at the onset of the QRS complex of the last tachy-
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pacing" has been applied in supraventricular and ventricular
arrhythmias (15). This pacingmode is usefulfor arrhythmias
that are not hemodynamically compromising and can be
terminated by single premature stimuli. Its success rate can
be increased by concomitant use of antiarrhythmic medi-
cations that slow conduction or lengthen the functional re-
fractory period of the reentrant circuit (6).
Scanningpacemakers have been shown to terminate ven-
tricular tachycardiaby delivering timed stimuli (8-13). Ra-
dio frequency extemally activated scanning pacemakers were
followed by automatically activated devices. We recently
reported (II) the successful use of a programmable auto-
matic scanning pacemaker to treat ventricular tachycardia.
The use of scanning single or double extrastimuli for ter-
minating tachyarrhythmias appearsto be safe, rarelycausing
rate acceleration or induction of ventricular fibrillation.
Burst stimuli have been reported to be useful in long-
term therapy of ventricular tachycardia (/-7,13). This mode
of antitachycardia pacing can be activated manually, by
radio frequency signal or automatically. A burst rate at least
30% greater than the tachycardia rate is generally needed
to terminate the arrhythmia (1-16,17). The mechanism
whereby burst stimuli terminate ventricular tachycardia has
not been established, although several mechanisms have
been proposed. The useof this methodof treatingventricular
tachycardia has been limited by reports of acceleration of
tachycardia in more than 40% of patients studied in elec-
trophysiology laboratories (1,18). Thus, investigators have
required at least 100 successful arrhythmia terminations
without rateacceleration before pacemaker implantation (1-5).
Therapeutic considerations. Our patient had recurrent,
hemodynamically significant ventricular tachycardia. Ad-
verseside effects or ineffectiveness,or both, limitedtherapy
with conventional antiarrhythmic agents alone or in com-
binationwitha beta-adrenergic blockingagent. Whiletaking
procainamide the patient had an in-hospital cardiac arrest,
probably secondary to drug-induced heart rate acceleration,
although the QT interval was normal and torsade de pointes
was not noted (singlechannel lead). The experimental agent
mexiletine was successfulin eliminatingsymptomsand Hol-
ter-recorded sustained ventriculartachycardia for more than
2 years, but symptomatic ventriculartachycardiaeventually
recurred. The patient refused several other investigational
antiarrhythmic medications including amiodarone, and an
electrophysiologic study was performed to test the efficacy
of antitachycardia pacing modalities.
Electrophysiologic studies utilizing double extrastimuli
at the right ventricularapex reproducibly inducedventricular
tachycardia. Single and double pacing stimuli delivered from
this site at multiple different coupling intervals were suc-
cessful in terminating 50% of induced ventricular tachy-
cardias. Synchronizing the first of six pacing spikes deliv-
ered at 240 pulses/min with the last sensed ventricular
complex, more than 250 successful terminations of ven-
tricular tachycardia were demonstrated before implantation
of the Cybertach-60 generator. Combinations of longer or
faster burst modes, or both, were also successful, without
rate acceleration. It was thought important to test other
modes of tachycardia terminationso that further reprogram-
ming, if needed, could be performed safely.
Follow-up. Thirty Holter ambulatory electrocardio-
graphic recordings over a 23 month follow-up period have
demonstrated 2,014 successful terminations of ventricular
tachycardia. No evidence for rate acceleration is present
although5 of the 2,014 terminationsrequireda secondburst
for termination. Reprogramming of the burst rateor duration
has not been needed because the patient remains asymp-
tomatic without dizziness, presyncope or syncope. During
maintenance treatment with nadolol, 40 rug/day, multiple
exercise tests after pacemaker implantation have shown no
abnormality and demonstrate a maximal sinus rate of less
than 137 beats/min, the programmed tachycardia recogni-
tion criterion.
Although the number of Holter recordings may seem
excessive, the investigational protocol as approved by the
hospital's internalreviewboard stipulatedat least two Holter
recordings/month for the first year after pacemaker implan-
tation. In this particular medical care setting, these Holter
readings added little expense other than paper costs. Ad-
ditionally, because the patient was a volunteer at the hos-
pital, time and transportation costs were not overridingcon-
siderations.
Conclusions. This report outlines the use of a burst
antitachycardia pacemaker in a patient with mitral valve
prolapse and symptomatic ventricular tachycardia. Before
pacemaker implantation the patient had multiple presyn-
copal and syncopal episodes, and one episode of aborted
sudden death. Conventional medications and one investi-
gational antiarrhythmic medicationwere therapeutically un-
successful. After pacemaker implantation, the patient is
asymptomatic with more than 2,000 Holter-documented
pacemaker terminations of ventricular tachycardia.
I thank Enriqueta Canedo for secretarial help and Lieutenant Colonel George
T. Abernathy. MD for reviewing the manuscript.
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